CorrlensCorrlens
Correlate

Correlation Analysis

Eli Lilly & Co. vs Medline Inc. Class A common stock

LLY vs MDLN

+0.108

Weak positive

When one moves up, the other tends to follow.

LLY logo

Eli Lilly & Co.

LLY

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Market cap 828.2B · 50,000 employees

M

Medline Inc. Class A common stock

MDLN

Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.

Market cap 35.6B · 45,000 employees

Dec 17, 2025 — Apr 7, 2026Daily75 data pointsStockStockHealthcare

Time Series

Relative Performance

Green: LLYGray: MDLN36 of 75 points (sampled)

Who Moves First

LLY leads MDLN by 1 day

LLY tends to move before MDLN.

After testing 13 timing shifts, the strongest relationship was +0.111 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.265

11 periods · Return correlation when both series rose

Both Falling

-0.495

11 periods · Return correlation when both series fell

Diverging

-0.420

13 periods · Return correlation when series moved apart

R-Squared

1.2%

Share of variance in one series explained by the other.

Trend Agreement

51.4%

How often both series moved in the same direction period-to-period.

Overlap Quality

75

Thin shared window — 75 usable pairs.

Significance

n.s.

95% CI: [-0.122, 0.327]

Scatter

XY Regression

859.99009501,0001,0501,1001,126.538.1540424446485050.49Eli Lilly & Co.Medline Inc. Class A common stockData pointsFit (r = 0.108)

Pipeline

Data quality details

Pipeline Summary

75 paired data points survived the daily window.

Raw input

1,254

75

Normalized

1,254

75

Prepared

1,254

75

Aligned

75

75

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

1,179

A: 1179 / B: 0

Series A

LLY logo

Eli Lilly & Co.

LLY

Market cap 828.2B · 50,000 employees

Stock · 1,254 raw → 1,254 prepared

Series B

M

Medline Inc. Class A common stock

MDLN

Market cap 35.6B · 45,000 employees

Stock · 75 raw → 75 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

11

Estimated crossover points between normalized spreads.

Slope

0.0044

Linear regression slope.

Intercept

39.3980

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 6 hours ago · ID: stock-lly-vs-stock-mdln-daily